Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth after administration of an anti-angiogenic agent, bevacizumab, as single-agent and combination therapy in tumor xenografts
- 浏览0

Cancer Chemotherapy and Pharmacology
1147-1157页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文